Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Silo Pharma (SILO) Return on Assets (2019 - 2025)

Silo Pharma (SILO) has disclosed Return on Assets for 7 consecutive years, with 0.6% as the latest value for Q4 2025.

  • Quarterly Return on Assets fell 5.0% to 0.6% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.6% through Dec 2025, down 5.0% year-over-year, with the annual reading at 0.56% for FY2025, 2.0% up from the prior year.
  • Return on Assets hit 0.6% in Q4 2025 for Silo Pharma, up from 0.78% in the prior quarter.
  • In the past five years, Return on Assets ranged from a high of 0.02% in Q2 2022 to a low of 0.78% in Q2 2025.
  • Historically, Return on Assets has averaged 0.33% across 5 years, with a median of 0.37% in 2021.
  • Biggest five-year swings in Return on Assets: soared 195bps in 2021 and later plummeted -54bps in 2023.
  • Year by year, Return on Assets stood at 0.01% in 2021, then crashed by -101bps to 0.0% in 2022, then tumbled by -575629bps to 0.54% in 2023, then decreased by -1bps to 0.55% in 2024, then decreased by -10bps to 0.6% in 2025.
  • Business Quant data shows Return on Assets for SILO at 0.6% in Q4 2025, 0.78% in Q3 2025, and 0.78% in Q2 2025.